Bio-Techne Corporation (TECH)
NASDAQ · Healthcare
Bio-Techne Corporation EBITDA 2009–2025
Bio-Techne Corporation annual/quarterly ebitda history and growth rate from 2009 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Bio-Techne Corporation ebitda for the quarter ending September 30, 2025 was 72.0 M, a 5.69% increase year-over-year.
- Bio-Techne Corporation ebitda for the twelve months ending September 30, 2025 was 307.5 M, a 19.94% increase year-over-year.
- Bio-Techne Corporation annual ebitda for 2025 was 212.2 M, a 33.37% decrease from 2024.
- Bio-Techne Corporation annual ebitda for 2024 was 318.4 M, a 21.61% decrease from 2023.
- Bio-Techne Corporation annual ebitda for 2023 was 406.2 M, a 2.14% increase from 2022.
- Bio-Techne Corporation annual ebitda for 2022 was 397.7 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bio-Techne Corporation EBITDA — FAQ
Bio-Techne Corporation (TECH) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TECH's ebitda history?
The chart and table above show Bio-Techne Corporation's ebitda by year and by quarter, including the growth rate.